Bristol-Myers Squibb [clinicaltrials_resource:d4c40cb9f02fd866ab671f3ce45dfa72]
Bristol-Myers Squibb [clinicaltrials_resource:021cb366135788f128cb03e1dd241fc6]Bristol-Myers Squibb [clinicaltrials_resource:0301e86154e8eb65a6d55413df528650]Bristol-Myers Squibb [clinicaltrials_resource:03f118a8d87fcb02db1d9e4809a55fd1]Bristol-Myers Squibb [clinicaltrials_resource:073f3f38d172c6c5692cf836900b70b4]Bristol-Myers Squibb [clinicaltrials_resource:08db3aefcd73bfcad956eae7b95e2437]Bristol-Myers Squibb [clinicaltrials_resource:09fdcaa75b5ec83a25e61890861861d0]Bristol-Myers Squibb [clinicaltrials_resource:0a3971ba9e3d73b03ffda7f2241c2be1]Bristol-Myers Squibb [clinicaltrials_resource:0b13de923af9d968ef8a3442b3590204]Bristol-Myers Squibb [clinicaltrials_resource:0c7107191f2178c151b5f188c7eeacc4]Bristol-Myers Squibb [clinicaltrials_resource:0d3d3c9a61d664d4e15740da2a7dc0d0]Mark Hibberd, MD, PhD [clinicaltrials_resource:0db35cb7715de9c4037f7be1c2916eba]Bristol-Myers Squibb [clinicaltrials_resource:0efd09c9293ed3779bcaba76dfd9f046]Bristol Myers Squibb [clinicaltrials_resource:0f39faf8420c948c7c5aa9bc5d7469fc]Bristol-Myers Squibb [clinicaltrials_resource:0f91098c233066da36e92b568e32b59d]Bristol-Myers Squibb [clinicaltrials_resource:1120b77677f44c1bed62eb5e86bbac4a]Bristol-Myers Squibb [clinicaltrials_resource:11b42bc8a3c268e6b623e45e8bb61c84]Martin Rosenberg, MD [clinicaltrials_resource:123ee73c19936230b6746288b99500fb]Bristol-Myers Squibb [clinicaltrials_resource:141d5960b6eead79f046d6e7fd8eb40f]Bristol-Myers Squibb [clinicaltrials_resource:162aadba09ea297936383cb5d3d86186]Bristol-Myers Squibb [clinicaltrials_resource:17242ba5a4f17449a0343ce99d156b21]Bristol-Myers Squibb [clinicaltrials_resource:188b84252b6ba28418cde17a51d3f575]Bristol-Myers Squibb [clinicaltrials_resource:1b5a24e71954f4f04f154d2317ad4699]Bristol-Myers Squibb [clinicaltrials_resource:1c95d0c048d8254d98fff44536483f2d]Bristol-Myers Squibb [clinicaltrials_resource:1d29faeddc1793c08384f73ba9eab1da]Bristol-Myers Squibb [clinicaltrials_resource:1eb389ee91b27abf719fde672debf9cc]Bristol-Myers Squibb [clinicaltrials_resource:24d22bdcc68977b27b9fd633179684fe]Bristol-Myers Squibb [clinicaltrials_resource:2a5b187e8b923349a0a0485adc7f48fd]Bristol-Myers Squibb [clinicaltrials_resource:2ff95b475eff014474cb080ff0ce6752]Bristol-Myers Squibb [clinicaltrials_resource:3198a154b3c6ab71c470cee213664836]Bristol-Myers Squibb [clinicaltrials_resource:335e2598b666f4aff6479408e088bc77]Bristol-Myers Squibb [clinicaltrials_resource:357ce4891c269c4509c8114c27434796]Bristol-Myers Squibb [clinicaltrials_resource:35a684d934f01de6dfad410572eb65ed]Bristol-Myers Squibb [clinicaltrials_resource:3d26e071bcd3dadfbfe0273b77e35b00]Robert Mittleman, MD [clinicaltrials_resource:3df85a888750bffa2b0e3b48c743f53a]Bristol-Myers Squibb [clinicaltrials_resource:400aba46933eb0890f3dfe8353257e37]Bristol-Myers Squibb [clinicaltrials_resource:402c765a3b9d363bc2b842f2dec811b9]Bristol-Myers Squibb [clinicaltrials_resource:425b27b965c944ec54f2aec82b674fbf]Bristol-Myers Squibb [clinicaltrials_resource:427d0168ebe9ece9357b0f1cfa092a6c]Bristol_Myers Squibb [clinicaltrials_resource:435586e85927b6cc0d048bdd97b567e6]Bristol-Myers Squibb [clinicaltrials_resource:43d63e31194df2735d9db67d9fab176d]
affiliation [clinicaltrials_vocabulary:affiliation]
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002420]BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy [clinicaltrials:NCT00004927]BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy [clinicaltrials:NCT00017043]Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00024284]clinicaltrials:NCT00084656Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes [clinicaltrials:NCT00094991]Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone [clinicaltrials:NCT00095030]clinicaltrials:NCT00095238Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria [clinicaltrials:NCT00095290]Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension [clinicaltrials:NCT00095394]Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension [clinicaltrials:NCT00095550]A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [clinicaltrials:NCT00095758]A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [clinicaltrials:NCT00095823]clinicaltrials:NCT00101608Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes [clinicaltrials:NCT00106808]clinicaltrials:NCT00110357clinicaltrials:NCT00110422clinicaltrials:NCT00112294Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [clinicaltrials:NCT00112346]MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00112580]A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide [clinicaltrials:NCT00135408]A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces [clinicaltrials:NCT00162110]A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [clinicaltrials:NCT00162318]To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine [clinicaltrials:NCT00207168]A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma [clinicaltrials:NCT00289627]Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma [clinicaltrials:NCT00289640]clinicaltrials:NCT00306202A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer [clinicaltrials:NCT00320255]clinicaltrials:NCT00324155Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) [clinicaltrials:NCT00352560]Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma [clinicaltrials:NCT00357461]A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma [clinicaltrials:NCT00362102]Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects [clinicaltrials:NCT00388609]clinicaltrials:NCT00493779clinicaltrials:NCT00496769clinicaltrials:NCT00508157DDI HV (ATV - Merck) [clinicaltrials:NCT00518297]clinicaltrials:NCT00528372clinicaltrials:NCT00528879
collaborator [clinicaltrials_vocabulary:collaborator]
A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) [clinicaltrials:NCT00002028]Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine [clinicaltrials:NCT00002035]Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [clinicaltrials:NCT00002041]Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC [clinicaltrials:NCT00002057]A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia [clinicaltrials:NCT00002067]A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [clinicaltrials:NCT00002168]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [clinicaltrials:NCT00002176]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [clinicaltrials:NCT00002177]A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients [clinicaltrials:NCT00002207]Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) [clinicaltrials:NCT00002224]Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002240]A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex [clinicaltrials:NCT00002246]A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers [clinicaltrials:NCT00002261]A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine [clinicaltrials:NCT00002274]A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine [clinicaltrials:NCT00002280]A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes [clinicaltrials:NCT00002293]A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition [clinicaltrials:NCT00002300]A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients [clinicaltrials:NCT00002307]A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs [clinicaltrials:NCT00002308]The Safety and Effectiveness of Megace in HIV-Infected Women [clinicaltrials:NCT00002345]A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. [clinicaltrials:NCT00002349]A Study of Lobucavir in Patients With AIDS [clinicaltrials:NCT00002352]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]A Study Comparing Two Forms of Didanosine in HIV-infected Patients [clinicaltrials:NCT00002360]A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002369]The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine [clinicaltrials:NCT00002371]A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs [clinicaltrials:NCT00002411]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002420]Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen [clinicaltrials:NCT00002429]Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [clinicaltrials:NCT00004584]BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy [clinicaltrials:NCT00004927]Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients [clinicaltrials:NCT00005918]A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [clinicaltrials:NCT00013897]BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy [clinicaltrials:NCT00017043]Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00024284]A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [clinicaltrials:NCT00028067]Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) [clinicaltrials:NCT00028301]A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors [clinicaltrials:NCT00030173]Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer [clinicaltrials:NCT00035152]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) [clinicaltrials:NCT00002028]Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine [clinicaltrials:NCT00002035]Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [clinicaltrials:NCT00002041]Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC [clinicaltrials:NCT00002057]A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia [clinicaltrials:NCT00002067]A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [clinicaltrials:NCT00002168]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [clinicaltrials:NCT00002176]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [clinicaltrials:NCT00002177]A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients [clinicaltrials:NCT00002207]Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) [clinicaltrials:NCT00002224]Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients [clinicaltrials:NCT00002234]Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002240]A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex [clinicaltrials:NCT00002246]A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers [clinicaltrials:NCT00002261]A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine [clinicaltrials:NCT00002274]A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine [clinicaltrials:NCT00002280]A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes [clinicaltrials:NCT00002293]A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition [clinicaltrials:NCT00002300]A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients [clinicaltrials:NCT00002307]A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs [clinicaltrials:NCT00002308]The Safety and Effectiveness of Megace in HIV-Infected Women [clinicaltrials:NCT00002345]A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. [clinicaltrials:NCT00002349]A Study of Lobucavir in Patients With AIDS [clinicaltrials:NCT00002352]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]A Study Comparing Two Forms of Didanosine in HIV-infected Patients [clinicaltrials:NCT00002360]A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002369]The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine [clinicaltrials:NCT00002371]A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs [clinicaltrials:NCT00002411]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002420]Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen [clinicaltrials:NCT00002429]Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [clinicaltrials:NCT00004584]BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy [clinicaltrials:NCT00004927]Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients [clinicaltrials:NCT00005918]A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [clinicaltrials:NCT00013897]BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy [clinicaltrials:NCT00017043]Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00024284]A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [clinicaltrials:NCT00028067]Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) [clinicaltrials:NCT00028301]A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors [clinicaltrials:NCT00030173]
source [clinicaltrials_vocabulary:source]
Bristol-Myers Squibb [clinicaltrials_resource:d4c40cb9f02fd866ab671f3ce45dfa72]
Bio2RDF identifier
d4c40cb9f02fd866ab671f3ce45dfa72
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d4c40cb9f02fd866ab671f3ce45dfa72
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:d4c40cb9f02fd866ab671f3ce45dfa72
title
Bristol-Myers Squibb
@en
type
label
Bristol-Myers Squibb [clinicaltrials_resource:d4c40cb9f02fd866ab671f3ce45dfa72]
@en